Furthermore, Wu et colleagues [6] revealed that BMI1 is a direct target of miR-16, i.e., increased miR-16 inhibits BMI1 and promotes apoptosis in NSCLC. This evidence concerns the gene BMI1 and non-small cell lung carcinoma.